Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0084
-0.0006 (-6.67%)
Feb 27, 2025, 3:47 PM EST
Evofem Biosciences Employees
As of December 31, 2023, Evofem Biosciences had 38 total employees, including 37 full-time and 1 part-time employees. The number of employees increased by 1 or 2.70% compared to the previous year.
Employees
38
Change (1Y)
1
Growth (1Y)
2.70%
Revenue / Employee
$449,947
Profits / Employee
-$290,000
Market Cap
906.85K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
SANUWAVE Health | 31 |
Silence Therapeutics | 109 |
Evofem Biosciences News
- 14 days ago - Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO - PRNewsWire
- 3 months ago - Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 - PRNewsWire
- 4 months ago - Evofem Secures Investor Support for Proposed Merger through Voting Agreements - PRNewsWire
- 6 months ago - Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution - PRNewsWire
- 7 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $4.16M - Seeking Alpha
- 7 months ago - Evofem Biosciences Announces Financial Results for the Second Quarter of 2024 - PRNewsWire
- 7 months ago - Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st - GlobeNewsWire
- 7 months ago - Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1 - PRNewsWire